Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
David Højland Ipsen, Jens Lykkesfeldt, Pernille Tveden‐Nyborg
Cellular and Molecular Life Sciences (2018) Vol. 75, Iss. 18, pp. 3313-3327
Open Access | Times Cited: 1114

Showing 26-50 of 1114 citing articles:

Luteolin as a potential hepatoprotective drug: Molecular mechanisms and treatment strategies
Chenhao Yao, Shu Dai, Cheng Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115464-115464
Open Access | Times Cited: 42
Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies
Mohammad Habibullah, Khaleed Jemmieh, Amr Ouda, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 31
Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy
Jihao Xu, Yifan Li, Zhaolan Feng, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 221-221
Open Access | Times Cited: 2
Mitochondrial targeted therapy in MAFLD
Sien Lai, Dongsheng Tang, Juan Feng
Biochemical and Biophysical Research Communications (2025) Vol. 753, pp. 151498-151498
Closed Access | Times Cited: 2
Metabolic dysfunction-associated steatotic liver disease in adults
Daniel Q. Huang, Vincent Wai‐Sun Wong, Mary E. Rinella, et al.
Nature Reviews Disease Primers (2025) Vol. 11, Iss. 1
Closed Access | Times Cited: 2
Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer
Rosa Divella, Antonio Mazzocca, Antonella Daniele, et al.
International Journal of Biological Sciences (2019) Vol. 15, Iss. 3, pp. 610-616
Open Access | Times Cited: 145
Naringin Attenuates High Fat Diet Induced Non-alcoholic Fatty Liver Disease and Gut Bacterial Dysbiosis in Mice
Hongna Mu, Qi Zhou, Ruiyue Yang, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 137
NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment
Giovanni Targher, Kathleen E. Corey, Christopher D. Byrne
Diabetes & Metabolism (2020) Vol. 47, Iss. 2, pp. 101215-101215
Open Access | Times Cited: 132
Relationship between Heart Disease and Liver Disease: A Two-Way Street
Hamza El Hadi, Angelo Di Vincenzo, Roberto Vettor, et al.
Cells (2020) Vol. 9, Iss. 3, pp. 567-567
Open Access | Times Cited: 127
Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants
Clémence Rives, Anne Fougerat, Sandrine Ellero‐Simatos, et al.
Biomolecules (2020) Vol. 10, Iss. 12, pp. 1702-1702
Open Access | Times Cited: 119
The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling
Samukelisiwe Shabalala, Phiwayinkosi V. Dludla, Lawrence Mabasa, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110785-110785
Open Access | Times Cited: 115
MicroRNA Networks Modulate Oxidative Stress in Cancer
Yang-Hsiang Lin
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4497-4497
Open Access | Times Cited: 105
AKR-001, an Fc-FGF21 Analog, Showed Sustained Pharmacodynamic Effects on Insulin Sensitivity and Lipid Metabolism in Type 2 Diabetes Patients
Allegra Kaufman, Lubna Abuqayyas, William S. Denney, et al.
Cell Reports Medicine (2020) Vol. 1, Iss. 4, pp. 100057-100057
Open Access | Times Cited: 102
Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
Francisco Idalsoaga, Anand V. Kulkarni, Omar Y. Mousa, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 102
Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC
Hyun-Mi Kim, Da Som Lee, Tae Hyeon An, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4495-4495
Open Access | Times Cited: 100
Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Chanbin Lee, Ji‐Eun Kim, Youngmi Jung
Cells (2019) Vol. 8, Iss. 10, pp. 1259-1259
Open Access | Times Cited: 99
Endoplasmic reticulum stress and protein degradation in chronic liver disease
Siwei Xia, Zhimin Wang, Sumin Sun, et al.
Pharmacological Research (2020) Vol. 161, pp. 105218-105218
Closed Access | Times Cited: 95
Oleanolic Acid Targets the Gut–Liver Axis to Alleviate Metabolic Disorders and Hepatic Steatosis
Chenyu Xue, Ying Li, Hao Lv, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 28, pp. 7884-7897
Closed Access | Times Cited: 92
Lactobacillus plantarum NA136 improves the non-alcoholic fatty liver disease by modulating the AMPK/Nrf2 pathway
Zijian Zhao, Chao Wang, Li Zhang, et al.
Applied Microbiology and Biotechnology (2019) Vol. 103, Iss. 14, pp. 5843-5850
Closed Access | Times Cited: 89
MicroRNA-29a Suppresses CD36 to Ameliorate High Fat Diet-Induced Steatohepatitis and Liver Fibrosis in Mice
Hung‐Yu Lin, Feng‐Sheng Wang, Ya‐Ling Yang, et al.
Cells (2019) Vol. 8, Iss. 10, pp. 1298-1298
Open Access | Times Cited: 89
Disturbances in Cholesterol Homeostasis and Non-alcoholic Fatty Liver Diseases
P.K. Malhotra, Ravinder K. Gill, Seema Saksena, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 89
Diet-induced alteration of intestinal stem cell function underlies obesity and prediabetes in mice
Alexandra Aliluev, Sophie Tritschler, Michael Sterr, et al.
Nature Metabolism (2021) Vol. 3, Iss. 9, pp. 1202-1216
Open Access | Times Cited: 89
Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates
Ashiq Khan, Zitong Ding, Muhammad Ishaq, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 3, pp. 818-833
Open Access | Times Cited: 86
Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease
Yingfei Xi, Hongshan Li
Biomedicine & Pharmacotherapy (2019) Vol. 121, pp. 109609-109609
Open Access | Times Cited: 85
Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD)
Andrea González, Camila Huerta-Salgado, Josué Orozco-Aguilar, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 84

Scroll to top